Abstract

Levothyroxine Sodium 40-micro-g/mL Oral Liquid

Author(s): Allen Loyd V Jr

Issue: May/Jun 2007 - Pain Management

Page(s): 247

Download in electronic PDF format for $75
  • Levothyroxine Sodium 40-micro-g/mL Oral Liquid Page 1

Abstract

A formulation for preparing Levothyroxine Sodium 40-micro-g/mL Oral Liquid. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • levothyroxine sodium
  • thyroid hormone replacement
  • hypothyroidism

Related Categories

  • FORMULATIONS
  • DOSAGE FORMS/DRUG CARRIERS
  • ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2007
Pg. 247
Levothyroxine Sodium 40-micro-g/mL Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2013
Pg. 505
Levothyroxine Sodium 100-mcg Capsules
Author(s): Allen Loyd V Jr
Jan/Feb 2025
Pg. 47
Levothyroxine Sodium 40-ug/mL Oral Liquid
Author(s):
Jul/Aug 2005
Pg. 268-273
Hypothyroidism: Optimizing Therapy with Slow-Release Compounded Thyroid Replacement
Author(s): Milner Martin
Sep/Oct 2015
Pg. 414-419
Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules
Author(s): Fortner Jeff, Salton Jason, Carlson Christie, Wheeler Rich, Cote Brianna, Rao Deepa
Jul/Aug 2010
Pg. 306-309
Thyroid Potency Calculations
Author(s): Stack Bob
Nov/Dec 2008
Pg. 488-497
Differentiation and Treatment of Hypothyroidism, Functional Hypothyroidism, and Functional Metabolism
Author(s): Paoletti Jim
Sep/Oct 2012
Pg. 376-380
Bioidentical Thyroid Replacement Therapy in Practice: Delivering a Physiologic T4-T3 Ratio for Improved Patient Outcomes with the Listecki-Snyder Protocol
Author(s): Snyder Scott, Listecki Robert E
Sep/Oct 2015
Pg. 428-431
Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures
Author(s): Nahata Milap C
Jan/Feb 2024
Pg. 34-43
Differentiation and Treatment of Hypothyroidism, Functional Hypothyroidism, and Functional Metabolism
Author(s): Paoletti Jim
Jan/Feb 2001
Pg. 52-54
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2
Author(s): Ford Gina, Garcia Lea
Jan/Feb 2017
Pg. 39-45
Basics of Compounding with Dilutions and Concentrates
Author(s): Allen Loyd V Jr
Jan/Feb 1997
Pg. 60-63
Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets
Author(s): Alexander Kenneth S, Kothapalli Madhu R, Dollimor David
Nov/Dec 2000
Pg. 482-483
Stability of Levothyroxine Sodium Injection in Polypropylene Syringes
Author(s): Gupta Vishnu D
Nov/Dec 2008
Pg. 546
Liothyronine Sodium (T3) 5-mcg/0.1-mL Transdermal Cream
Author(s): Allen Loyd V Jr
Nov/Dec 2008
Pg. 545
Liothyronine Sodium (T3) 5-mcg/Hydrocortisone 5-mg Slow-Release Capsules
Author(s): Allen Loyd V Jr
Sep/Oct 2017
Pg. 418-425
Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3)
Author(s): Bakhteyar Hamid, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
Jan/Feb 2007
Pg. 78
Prednisolone Sodium Phosphate 10-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Mar/Apr 2018
Pg. 164-171
The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions
Author(s): Svirskis Darren, Lin Shao-Wei, Brown Helen, Sangaroomthong Annie, Shin Daniel, Wang Ziqi, Xu Hongtao, Dean Rebecca, Vareed Preetika, Jensen Maree, Wu Zimei